“…For several years, our group has disclosed efficient methodologies to selectively functionalize bicyclic [5,5] heterocycles such as [1,2,4]triazolo[3,4- b ][1,3,4]thiadiazoles, 20 thiazolo[3,2- b ][1,2,4]triazoles 21 and more specially, imidazo[2,1- b ][1,3,4]thiadiazoles. 22–26 The latter have proven applicable to the discovery of a wide variety of biological molecules. Surprisingly, one of the isomers, the imidazo[1,2- d ][1,2,4]thiadiazole core, has seldom been described, and is reported in only a few references, where it has shown its potential as a therapeutic agent, especially as a Factor XIIIa inhibitor.…”